HomeStock ScreenerKrsnaa Diagnostics

Krsnaa Diagnostics Share Price | Krsnaa Diagnostics Stock Screener

KRSNAA Healthcare Service Provider
Share Price NSE
₹538.45
▼ -10.50 (-1.91%)
2026-05-27 00:00:00
Share Price BSE
₹539.20
▼ -9.70 (-1.77%)
2026-05-27 00:00:00
As of May 27, 2026, the Krsnaa Diagnostics share price (NSE: KRSNAA) is ₹538.45 on NSE and ₹539.20 on BSE, down 1.91% from the previous close, with shares trading between ₹536.10 and ₹552.25, and a 52-week range of ₹520.30–₹869.90. Check KRSNAA 52-week high low for the annual price range and momentum. Use the Krsnaa Diagnostics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Krsnaa Diagnostics Market Cap ₹1,780.72 Cr.
KRSNAA P/E Ratio (TTM) 22.68
Krsnaa Diagnostics P/B Ratio 1.95
EPS (TTM) ₹23.04
Dividend Yield 0.49%
Debt to Equity 0.21
KRSNAA 52 Week High ₹869.90
Krsnaa Diagnostics 52 Week Low ₹520.30
Operating Margin 28.00%
Profit Margin 18.75%
KRSNAA Revenue (TTM) ₹224.00
EBITDA ₹86.00
Net Income ₹42.00
Total Assets ₹1,282.00
Total Equity ₹883.00

Krsnaa Diagnostics Share Price Chart

Screen Krsnaa Diagnostics share price with an interactive chart. Analyse KRSNAA price trends and volatility across different timeframes.

Krsnaa Diagnostics Company Profile - Fundamental Screener

Screen Krsnaa Diagnostics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRSNAA shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE08LI01020

Krsnaa Diagnostics Balance Sheet Screener

Screen KRSNAA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022
Assets
Total Assets 1,282 1,172 910 876
Current Assets 415 421 223 334
Fixed Assets 670 647 471 386
Liabilities
Total Liabilities 0 0 0 0
Current Liabilities 93 81 72 71
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 883 810 739 684
Share Capital 16 16 16 16
Reserves & Surplus 867 794 723 669

Krsnaa Diagnostics Income Statement Screener - Profit & Revenue Analysis

Screen Krsnaa Diagnostics income statement and profit fundamentals. Analyze KRSNAA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Krsnaa Diagnostics share price evaluation.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun
Revenue 224 191 197 210 185 171 178 191 184 139 144 160 162 112 118
Expenses 138 133 142 147 135 123 128 137 129 99 108 124 121 80 85
EBITDA 86 57 55 63 50 48 50 54 54 40 36 36 42 32 32
Operating Profit % 28.00% 28.00% 27.00% 29.00% 26.00% 26.00% 25.00% 27.00% 26.00% 26.00% 22.00% 20.00% 24.00% 26.00% 25.00%
Depreciation 23 22 22 24 23 18 22 22 23 15 16 20 21 10 12
Interest 12 7 6 8 8 7 5 6 6 2 2 3 4 2 1
Profit Before Tax 52 29 27 32 20 23 23 25 26 24 18 13 16 20 19
Tax 10 8 7 8 4 4 5 6 6 5 3 3 3 2 5
Net Profit 42 21 21 24 15 19 18 20 19 19 15 11 13 18 14
EPS 12.86 6.40 6.35 7.38 4.72 5.80 5.55 6.07 6.01 6.03 4.66 3.35 4.09 5.40 4.53

Krsnaa Diagnostics Cash Flow Screener - Liquidity Fundamentals

Screen KRSNAA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2024-March 2023-March 2022-March 2017-March 2016-March
Operating Activities 24 76 128 64 -23
Investing Activities -129 -109 -241 -54 -47
Financing Activities 84 -33 176 -41 105
Net Cash Flow -20 -66 64 -31 36

Krsnaa Diagnostics Shareholding Pattern Screener

See Krsnaa Diagnostics shareholding pattern with promoter, FII, and DII holdings. Check Krsnaa Diagnostics promoter holding and ownership changes for KRSNAA on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 27.11% 27.24% 27.11% 27.11% 27.11% 27.03% 27.17% 27.17%
FII Holding 3.91% 3.55% 3.40% 3.67% 4.17% 3.34% 3.33% 3.63%
DII Holding 13.89% 14.26% 14.24% 14.96% 13.86% 15.37% 15.26% 15.86%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.68% 29.13% 28.95% 27.40% 27.84% 27.72% 28.73% 28.41%
Other Holding 26.40% 25.81% 26.30% 26.86% 27.01% 26.54% 25.51% 24.94%
Shareholder Count 53,022 53,559 54,262 52,117 52,380 56,458 55,914 53,519

Krsnaa Diagnostics Share Dividend Screener - Share Yield Analysis

Check Krsnaa Diagnostics dividend history with payout and yield data. View Krsnaa Diagnostics dividend details including ex-dates and amounts for KRSNAA stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹2.75 0.53%
2024-March ₹2.50 0.32%
2023-March ₹2.75 0.45%
2022-March ₹2.50 0.56%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Krsnaa Diagnostics Stock Index Membership

See which indices include Krsnaa Diagnostics stock. Check KRSNAA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

Krsnaa Diagnostics Market Events Screener - Corporate Actions

Get Krsnaa Diagnostics corporate actions including splits, bonuses, and buybacks. Check Krsnaa Diagnostics stock events that may affect KRSNAA share price.
Announcement Date Record Date Event Type Information Price Impact
Dividend ₹ 2.75 /share 19.21%
Dividend ₹ 2.75 /share 29.48%
Dividend ₹ 2.50 /share 30.69%
Annual General Meeting NA 34.63%
Dividend ₹ 2.50 /share -2.35%
Annual General Meeting NA -2.35%
2026-05-25 2026-05-25 Quarterly Result Announcement NA -3.83%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 2.01%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -5.32%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 1.72%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -0.98%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.19%
2024-10-25 2024-10-25 Quarterly Result Announcement NA -3.08%

Krsnaa Diagnostics Competitors Screener - Peer Comparison

Screen KRSNAA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 26,876 53.50 2,763 8.15% 510 55.66
Vijaya Diagnostic Centre 12,961 72.87 814 16.36% 182 60.54
Metropolis Healthcare 11,213 56.27 1,646 22.25% 185 62.69
Thyrocare Technologies 7,994 45.59 829 18.06% 156 71.28
Nephrocare Health Services 6,092 79.31 999 29.74% 62 56.47
Krsnaa Diagnostics 1,781 22.68 743 16.70% 78 32.60
Suraksha Diagnostic 1,539 51.38 310 21.30% 34 51.56
3B BlackBio DX 1,028 17.70 112 28.72% 48 41.85
Health X Platform 999 33.22 1,171 -18.47% -134 64.03
One Global Service Provider 852 14.18 148 134.60% 19 40.48

Krsnaa Diagnostics Company Announcements - News Screener

Screen KRSNAA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
Announcement under Regulation 30 (LODR)-Investor Presentation -
Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-05-28 Appointment/Re-Appointment Of Auditors -
2026-05-28 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-28 Corporate Action-Board approves Dividend -
2026-05-28 Financial Results For Quarter And Year Ended On March 31 2026 -
2026-05-28 Board Meeting Outcome for Outcome Of Board Meeting Held On May 25 2026 -
2026-05-24 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-05-23 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-05-23 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-05-22 Board Meeting Intimation for Quarter And Year Ended March 31 2026. -
2026-04-28 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-17 Announcement under Regulation 30 (LODR)-Change in Management -
2026-04-17 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-04-17 Board Meeting Held On April 17 2026. -
2026-04-16 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-04-16 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-04-04 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-27 Announcement under Regulation 30 (LODR)-Change in Management -